TB Research

Study to Investigate the Safety and Efficacy of GC3107 (BCG Vaccine) in Healthy Adults

Woo Joo Kim, M.D, Ph.D

Abstract

Healthy adults will be once administered GC3107(BCG Vaccine) Intradermally.

Healthy adults will be once administered GC3107(BCG Vaccine) Intradermally. Tuberculin Skin Test(TST) will be conducted after 84+7 days after IP injection and TST result will be read in 48\~72 hours.

MeSH terms

  • Tuberculosis